TDP43 pathology in chronic traumatic encephalopathy retinas
- PMID: 37737191
- PMCID: PMC10515050
- DOI: 10.1186/s40478-023-01650-6
TDP43 pathology in chronic traumatic encephalopathy retinas
Abstract
Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repetitive head trauma. Brain pathology in CTE is characterized by neuronal loss, gliosis, and a distinctive pattern of neuronal accumulation of hyper-phosphorylated tau (p-tau) and phospho-TDP43 (p-TDP43). Visual anomalies have been reported by patients with CTE, but the ocular pathology underlying these symptoms is unknown. We evaluated retinal pathology in post-mortem eyes collected from 8 contact sport athletes with brain autopsy-confirmed stage IV CTE and compared their findings to retinas from 8 control patients without CTE and with no known history of head injury. Pupil-optic nerve cross sections were prepared and stained with hematoxylin and eosin (H&E), p-tau, p-TDP43, and total TDP43 by immunohistochemistry. No significant retinal degeneration was observed in CTE eyes compared to control eyes by H&E. Strong cytoplasmic p-TDP43 and total TDP43 staining was found in 6/8 CTE eyes in a subset of inner nuclear layer interneurons (INL) of the retina, while only 1/8 control eyes showed similar p-TDP43 pathology. The morphology and location of these inner nuclear layer interneurons were most compatible with retinal horizontal cells, although other retinal cell types present in INL could not be ruled out. No p-tau pathology was observed in CTE or control retinas. These findings identify novel retinal TDP43 pathology in CTE retinas and support further investigation into the role of p-TDP43 in producing visual deficits in patients with CTE.
Keywords: Chronic traumatic encephalopathy (CTE); Eye pathology; Inner nuclear layer; Retina; TDP43; Tau.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





References
-
- Alosco ML, Cherry JD, Huber BR, Tripodis Y, Baucom Z, Kowall NW, Saltiel N, Goldstein LE, Katz DI, Dwyer B, et al. Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme. Acta Neuropathol. 2020;140:495–512. doi: 10.1007/s00401-020-02197-9. - DOI - PMC - PubMed
-
- Bieniek KF, Cairns NJ, Crary JF, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl DP, Stein TD, Vonsattel JP, et al. The second NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. J Neuropathol Exp Neurol. 2021;80:210–219. doi: 10.1093/jnen/nlab001. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- RF1 NS122854/NS/NINDS NIH HHS/United States
- RF1 NS121992/NS/NINDS NIH HHS/United States
- R01 NS069566/NS/NINDS NIH HHS/United States
- R37 NS076896/NS/NINDS NIH HHS/United States
- R01 NS076896/NS/NINDS NIH HHS/United States
- I01 BX005161/BX/BLRD VA/United States
- R01 NS088485/NS/NINDS NIH HHS/United States
- K23 NS102399/NS/NINDS NIH HHS/United States
- P30 EY026877/EY/NEI NIH HHS/United States
- P30 AG066515/AG/NIA NIH HHS/United States
- R21 NS135426/NS/NINDS NIH HHS/United States
- P30 AG072978/AG/NIA NIH HHS/United States
- P30 AG062429/AG/NIA NIH HHS/United States
- U54 NS115266/NS/NINDS NIH HHS/United States
- RF1 AG054156/AG/NIA NIH HHS/United States